Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)
NCT00078221
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
180
Enrollment
INDUSTRY
Sponsor class
Conditions
Macular Degeneration
Interventions
DEVICE:
Rheopheresis blood filtration
Sponsor
OccuLogix